Management: Part II—Drugs
- 12 October 2006
- Vol. 333 (7572) , 794-797
- https://doi.org/10.1136/bmj.333.7572.794
Abstract
No abstract availableKeywords
This publication has 7 references indexed in Scilit:
- Low-dose leptin reverses skeletal muscle, autonomic, and neuroendocrine adaptations to maintenance of reduced weightJournal of Clinical Investigation, 2005
- Safety of obesity drugsExpert Opinion on Drug Safety, 2005
- The endocannabinoid system and the treatment of obesityAnnals of Medicine, 2005
- Novel therapeutic targets for appetite regulation.2005
- OrlistatDrugs, 2004
- Predictive value of early weight loss in obesity management with orlistat: an evidence-based assessment of prescribing guidelinesInternational Journal of Obesity, 2003
- A Health Economic Model to Assess the Long-Term Effects and Cost-Effectiveness of Orlistat in Obese Type 2 Diabetic PatientsDiabetes Care, 2002